Evidence map›Paper›PMID 36226563›Full record

ArticleJournal of cellular and molecular medicine2022

Role of TNFSF15 variants in oral cancer development and clinicopathologic characteristics.

Hsueh-Ju Lu, Chun-Yi Chuang, Chun-Wen Su, Mu-Kuan Chen, Wei-En Yang, Chia-Ming Yeh, Chih-Hsin Tang, Chiao-Wen Lin, Shun-Fa Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Impact ofOncology research · 2026
    Article
  3. Association ofInternational journal of medical sciences · 2026
    Article
  4. Article
  5. Potential impact ofInternational journal of medical sciences · 2026
    Article
  6. International journal of medical sciences · 2025
    Article
  7. The impact of long non-coding RNAJournal of Cancer · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The impacts ofJournal of Cancer · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hsueh-Ju LuDivision of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Chun-Yi ChuangSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chun-Wen SuDepartment of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
Mu-Kuan ChenInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Wei-En YangDepartment of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
Chia-Ming YehInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chih-Hsin TangSchool of Medicine, China Medical University, Taichung, Taiwan.ORCID 0000-0002-7113-8352
Chiao-Wen LinInstitute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Shun-Fa YangDepartment of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.ORCID 0000-0002-0365-7927
Chung Shan Medical University Hospital · TWChanghua Christian Hospital · TWAsia University · TW

Funding

Chung Shan Medical University Hospital CSH-2022-C-014
6 · The paper itself

Abstract

Tumour necrosis family superfamily (TNFSF) member 15 (TNFSF15), encoded by TNFSF15, regulates immune responses and inflammation. However, the roles of TNFSF15 single-nucleotide variants (SNVs; formerly SNPs) in oral cavity squamous cell carcinoma (OCSCC) remain unclear. This case-control study included 2523 participants (1324 patients with OCSCC [52.5%] and 1199 healthy controls [47.5%]). The effects of TNFSF15 rs3810936, rs6478108 and rs6478109 on cancer development and prognosis were analysed by real-time PCR genotype assay. The Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases were used to validate our findings. The results demonstrated that the patients with altered TNFSF15 SNVs had poorer histological differentiation than did those with wild-type alleles. TNFSF15 SNVs were significantly associated with moderate-to-poor histological differentiation in univariate logistic regression. In the GTEx database, the expression of altered TNFSF15 SNVs in whole blood was lower than that of wild-type alleles. However, the expression of altered SNVs in the upper aerodigestive mucosa was higher than that of wild-type alleles. In the TCGA database, the patients with higher TNFSF15 expression had shorter overall survival than did those with lower TNFSF15 expression, especially for human papillomavirus-negative and advanced staging groups. In conclusion, although TNFSF15 SNVs did not affect OCSCC development, the patients with altered TNFSF15 SNVs exhibited poorer histological differentiation. The patients with higher TNFSF15 expression had poorer prognosis than did those with lower TNFSF15 expression.

Indexed as

Genetic Predisposition to DiseaseMouth NeoplasmsCase-Control StudiesGenotypeHumansPolymorphism, Single NucleotideTumor Necrosis Factor Ligand Superfamily Member 15TNFSF15 protein, humanTumor Necrosis Factor Ligand Superfamily Member 15oral cavity squamous cell carcinomapolymorphismsurvivalTNFSF15

Identifiers

PMID36226563
PMCPMC9639028
OpenAlexW4304889662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.